These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 27889455)

  • 1. In vivo evaluation of [
    Prabhakaran J; Solingapuram Sai KK; Zanderigo F; Rubin-Falcone H; Jorgensen MJ; Kaplan JR; Tooke KI; Mintz A; Mann JJ; Kumar JSD
    Bioorg Med Chem Lett; 2017 Jan; 27(1):21-23. PubMed ID: 27889455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and in vitro evaluation of [18F]FECIMBI-36: A potential agonist PET ligand for 5-HT2A/2C receptors.
    Prabhakaran J; Underwood MD; Kumar JS; Simpson NR; Kassir SA; Bakalian MJ; Mann JJ; Arango V
    Bioorg Med Chem Lett; 2015 Sep; 25(18):3933-6. PubMed ID: 26253634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent
    Petersen IN; Villadsen J; Hansen HD; Jensen AA; Lehel S; Gillings N; Herth MM; Knudsen GM; Kristensen JL
    Bioorg Med Chem; 2016 Nov; 24(21):5353-5356. PubMed ID: 27624522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ; Stepanov V; Ettrup A; Nakao R; Amini N; Svedberg M; Lehmann C; Hansen M; Knudsen GM; Halldin C
    Neuroimage; 2014 Jan; 84():342-53. PubMed ID: 23994452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and evaluation of (18)F-labeled 5-HT2A receptor agonists as PET ligands.
    Herth MM; Petersen IN; Hansen HD; Hansen M; Ettrup A; Jensen AA; Lehel S; Dyssegaard A; Gillings N; Knudsen GM; Kristensen JL
    Nucl Med Biol; 2016 Aug; 43(8):455-62. PubMed ID: 27209485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiosynthesis and evaluation of 11C-CIMBI-5 as a 5-HT2A receptor agonist radioligand for PET.
    Ettrup A; Palner M; Gillings N; Santini MA; Hansen M; Kornum BR; Rasmussen LK; Någren K; Madsen J; Begtrup M; Knudsen GM
    J Nucl Med; 2010 Nov; 51(11):1763-70. PubMed ID: 20956470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of 5-HT2A and 5-HT2C receptors in R(-)-2,5-dimethoxy-4-iodoamphetamine-elicited head twitch behavior in mice.
    Fantegrossi WE; Simoneau J; Cohen MS; Zimmerman SM; Henson CM; Rice KC; Woods JH
    J Pharmacol Exp Ther; 2010 Dec; 335(3):728-34. PubMed ID: 20858706
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Petersen IN; Villadsen J; Hansen HD; Madsen J; Jensen AA; Gillings N; Lehel S; Herth MM; Knudsen GM; Kristensen JL
    Org Biomol Chem; 2017 May; 15(20):4351-4358. PubMed ID: 28474719
    [No Abstract]   [Full Text] [Related]  

  • 9. Synthesis, radiofluorination, and preliminary evaluation of the potential 5-HT
    Edgar FG; Hansen HD; Leth-Petersen S; Ettrup A; Kristensen JL; Knudsen GM; Herth MM
    J Labelled Comp Radiopharm; 2017 Oct; 60(12):586-591. PubMed ID: 28856700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.
    Canal CE; Morgan D; Felsing D; Kondabolu K; Rowland NE; Robertson KL; Sakhuja R; Booth RG
    J Pharmacol Exp Ther; 2014 May; 349(2):310-8. PubMed ID: 24563531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and pharmacological evaluation of N-benzyl substituted 4-bromo-2,5-dimethoxyphenethylamines as 5-HT2A/2C partial agonists.
    Hansen M; Jacobsen SE; Plunkett S; Liebscher GE; McCorvy JD; Bräuner-Osborne H; Kristensen JL
    Bioorg Med Chem; 2015 Jul; 23(14):3933-7. PubMed ID: 25583099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
    Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL
    ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
    Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the serotonin 5-HT2A and 5-HT2C receptor ligands on the discriminative stimulus effects of nicotine in rats.
    Zaniewska M; McCreary AC; Przegaliński E; Filip M
    Eur J Pharmacol; 2007 Oct; 571(2-3):156-65. PubMed ID: 17617403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
    Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
    Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radiosynthesis and in vivo evaluation of a series of substituted 11C-phenethylamines as 5-HT (2A) agonist PET tracers.
    Ettrup A; Hansen M; Santini MA; Paine J; Gillings N; Palner M; Lehel S; Herth MM; Madsen J; Kristensen J; Begtrup M; Knudsen GM
    Eur J Nucl Med Mol Imaging; 2011 Apr; 38(4):681-93. PubMed ID: 21174090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of serotonin (5-HT)2 receptor-targeting ligands on locomotor responses to nicotine-repeated treatment.
    Zaniewska M; McCreary AC; Wydra K; Filip M
    Synapse; 2010 Jul; 64(7):511-9. PubMed ID: 20196140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical safety assessment of the 5-HT2A receptor agonist PET radioligand [ 11C]Cimbi-36.
    Ettrup A; Holm S; Hansen M; Wasim M; Santini MA; Palner M; Madsen J; Svarer C; Kristensen JL; Knudsen GM
    Mol Imaging Biol; 2013 Aug; 15(4):376-83. PubMed ID: 23306971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of vabicaserin (SCA-136), a selective 5-hydroxytryptamine 2C receptor agonist.
    Dunlop J; Watts SW; Barrett JE; Coupet J; Harrison B; Mazandarani H; Nawoschik S; Pangalos MN; Ramamoorthy S; Schechter L; Smith D; Stack G; Zhang J; Zhang G; Rosenzweig-Lipson S
    J Pharmacol Exp Ther; 2011 Jun; 337(3):673-80. PubMed ID: 21402690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of serotonin 2C receptor agonists on the behavioral and neurochemical effects of cocaine in squirrel monkeys.
    Manvich DF; Kimmel HL; Howell LL
    J Pharmacol Exp Ther; 2012 May; 341(2):424-34. PubMed ID: 22328576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.